[go: up one dir, main page]

PL1693064T3 - Leczenie utraty wagi za pomocą S. boulardii u pacjentów cierpiących na choroby zapalne jelit - Google Patents

Leczenie utraty wagi za pomocą S. boulardii u pacjentów cierpiących na choroby zapalne jelit

Info

Publication number
PL1693064T3
PL1693064T3 PL05292721T PL05292721T PL1693064T3 PL 1693064 T3 PL1693064 T3 PL 1693064T3 PL 05292721 T PL05292721 T PL 05292721T PL 05292721 T PL05292721 T PL 05292721T PL 1693064 T3 PL1693064 T3 PL 1693064T3
Authority
PL
Poland
Prior art keywords
weight loss
inflammatory bowel
boulardii
bowel diseases
patients suffering
Prior art date
Application number
PL05292721T
Other languages
English (en)
Inventor
Bernard Hublot
Hervé Groux
Paul Bernasconi
Rene Levy
Guern Marie-Emmanuelle Le
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of PL1693064T3 publication Critical patent/PL1693064T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
PL05292721T 2004-12-23 2005-12-16 Leczenie utraty wagi za pomocą S. boulardii u pacjentów cierpiących na choroby zapalne jelit PL1693064T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/895,455 US7799328B2 (en) 2004-12-23 2004-12-23 Method for treating weight loss in patients suffering from inflammatory bowel diseases
EP05292721A EP1693064B1 (en) 2004-12-23 2005-12-16 Treating weight loss in patients suffering from inflammatory bowel diseases with S. boulardii

Publications (1)

Publication Number Publication Date
PL1693064T3 true PL1693064T3 (pl) 2010-02-26

Family

ID=36143315

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05292721T PL1693064T3 (pl) 2004-12-23 2005-12-16 Leczenie utraty wagi za pomocą S. boulardii u pacjentów cierpiących na choroby zapalne jelit

Country Status (6)

Country Link
US (1) US7799328B2 (pl)
EP (1) EP1693064B1 (pl)
AT (1) ATE446102T1 (pl)
DE (1) DE602005017241D1 (pl)
ES (1) ES2333022T3 (pl)
PL (1) PL1693064T3 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
DE102007041588A1 (de) * 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
HRP20171632T1 (hr) * 2007-12-26 2017-12-15 Lesaffre Et Compagnie Pripravak za ljudsku i/ili životinjsku ishranu, njegova upotreba i kvasci
FR2928652B1 (fr) * 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
RU2427389C2 (ru) 2009-10-09 2011-08-27 Александр Владимирович Диковский Фармацевтическая композиция для профилактики и лечения инфекционных и неинфекционных диарей
FR2953412B1 (fr) * 2009-12-08 2012-04-20 Biocodex Medicament pour le traitement des ulceres gastro-intestinaux
WO2012012146A2 (en) * 2010-06-30 2012-01-26 The Regents Of The University Of Colorado Compositions and methods to modulate progression and onset of inflammatory bowel disease
IT1405757B1 (it) * 2010-11-03 2014-01-24 Gruppo Farmaimpresa Srl Preparazione farmaceutica comprendente saccaromyces e simeticone per il trattamento delle patologie gastrointestinali
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3664823B1 (en) 2017-08-07 2024-06-05 Finch Therapeutics Holdings LLC Composition for use in preventing or treating an enterococcal blood stream infection
JP2022541795A (ja) 2019-07-19 2022-09-27 フィンチ セラピューティクス ホールディングス エルエルシー 胃腸障害の治療のための方法および産物
WO2021050965A1 (en) 2019-09-13 2021-03-18 Crestovo Holdings Llc Compositions and methods for treating autism spectrum disorder
US20240226187A9 (en) 2019-10-18 2024-07-11 Finch Therapeutics Holdings Llc Compositions and Methods for Delivering a Bacterial Metabolite to a Subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.
US4595590A (en) 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
US4995590A (en) * 1990-05-15 1991-02-26 Close Gregg V Fence post installation
JP2001055338A (ja) 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物

Also Published As

Publication number Publication date
ATE446102T1 (de) 2009-11-15
ES2333022T3 (es) 2010-02-16
EP1693064A1 (en) 2006-08-23
US20060140973A1 (en) 2006-06-29
EP1693064B1 (en) 2009-10-21
US7799328B2 (en) 2010-09-21
DE602005017241D1 (de) 2009-12-03

Similar Documents

Publication Publication Date Title
PL1693064T3 (pl) Leczenie utraty wagi za pomocą S. boulardii u pacjentów cierpiących na choroby zapalne jelit
EP1742641A4 (en) METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES
IL176960A0 (en) Compositions and methods of treatment for inflammatory diseases
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
PT1827441E (pt) Combinações para o tratamento de doenças que envolvem proliferação celular
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
EP1706112A4 (en) METHODS FOR TREATING INFLAMMATORY DISEASE
ZA200700904B (en) Method of treating sjögren's syndrome
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
EP1594510A4 (en) METHOD AND KIT FOR REDUCING SYMPTOMS OF DISORDERS OF THE PERIPHERAL VASCULAR SYSTEM
EP1611120A4 (en) NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2006012641A3 (en) Methods for detecting and treating autoimmune disorders
EP1744740A4 (en) PHENOXYALKYCARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2007147868A3 (en) Prevention of muscle atrophy
WO2007014943A3 (en) Therapy for neurological diseases
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
EP1740221A4 (en) METHOD AND COMPOSITIONS FOR TREATING POLYCYSTIC DISEASES
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
MY144089A (en) A medicament related to mirtazapine for the treatment of hot flush
WO2007047205A3 (en) Enzyme inhibitors of pai-1
SI1812797T1 (sl) Pripravki in metode zdravljenja ter preprečevanja hiperprolifetarivnih bolezni
EP1781318A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF POLYKYSTIC DISEASES
GB0526394D0 (en) Treatment of inflammatory diseases